Genesis Healthcare Inc (NYSE:GEN) shares rose 6.6% during trading on Thursday . The stock traded as high as $2.44 and last traded at $2.59. Approximately 36,434 shares traded hands during trading, a decline of 95% from the average daily volume of 704,384 shares. The stock had previously closed at $2.43.
GEN has been the subject of several analyst reports. Stifel Nicolaus set a $2.00 price target on shares of Genesis Healthcare and gave the stock a “hold” rating in a report on Tuesday, April 24th. ValuEngine cut shares of Genesis Healthcare from a “buy” rating to a “hold” rating in a report on Monday, April 2nd. Finally, Stephens reiterated a “hold” rating and set a $2.00 price target on shares of Genesis Healthcare in a report on Monday, March 19th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Genesis Healthcare presently has a consensus rating of “Hold” and a consensus price target of $2.00.
The company has a debt-to-equity ratio of -2.80, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market capitalization of $366.72 million, a P/E ratio of -1.23 and a beta of 1.00.
Several institutional investors have recently modified their holdings of the company. V3 Capital Management L.P. boosted its holdings in shares of Genesis Healthcare by 2.0% in the 4th quarter. V3 Capital Management L.P. now owns 2,261,899 shares of the company’s stock valued at $1,726,000 after buying an additional 44,500 shares in the last quarter. BSW Wealth Partners boosted its holdings in shares of Genesis Healthcare by 74.2% in the 1st quarter. BSW Wealth Partners now owns 115,000 shares of the company’s stock valued at $174,000 after buying an additional 49,000 shares in the last quarter. California Public Employees Retirement System boosted its holdings in shares of Genesis Healthcare by 23.3% in the 1st quarter. California Public Employees Retirement System now owns 309,910 shares of the company’s stock valued at $468,000 after buying an additional 58,610 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Genesis Healthcare by 40.6% in the 1st quarter. Millennium Management LLC now owns 338,678 shares of the company’s stock valued at $511,000 after buying an additional 97,834 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. acquired a new position in shares of Genesis Healthcare in the 1st quarter valued at $153,000. Institutional investors and hedge funds own 18.70% of the company’s stock.
Genesis Healthcare Company Profile
Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.
Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.